PL2654897T3 - Sposób zwiększania tempa implantacji zarodka w macicy matki u ssaków, zastosowanie skutecznej ilości lektyny wiążącej betagalaktozyd lub jej pochodnych, lektyna wiążąca betagalaktozyd lub pochodne i produkt - Google Patents
Sposób zwiększania tempa implantacji zarodka w macicy matki u ssaków, zastosowanie skutecznej ilości lektyny wiążącej betagalaktozyd lub jej pochodnych, lektyna wiążąca betagalaktozyd lub pochodne i produktInfo
- Publication number
- PL2654897T3 PL2654897T3 PL11805370T PL11805370T PL2654897T3 PL 2654897 T3 PL2654897 T3 PL 2654897T3 PL 11805370 T PL11805370 T PL 11805370T PL 11805370 T PL11805370 T PL 11805370T PL 2654897 T3 PL2654897 T3 PL 2654897T3
- Authority
- PL
- Poland
- Prior art keywords
- galactoside
- beta
- derivatives
- binding lectin
- uterus
- Prior art date
Links
- 102000007563 Galectins Human genes 0.000 title 2
- 108010046569 Galectins Proteins 0.000 title 2
- 241000124008 Mammalia Species 0.000 title 1
- 230000032692 embryo implantation Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000004291 uterus Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1732—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/178—Lectin superfamily, e.g. selectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1005702A BRPI1005702B1 (pt) | 2010-12-21 | 2010-12-21 | método para aumentar a taxa de implantação de embriões no útero materno em mamíferos, uso de uma quantidade eficaz de uma lectina ligante de beta-galactosídeo ou derivados da mesma e produto |
| PCT/BR2011/000454 WO2012083396A1 (en) | 2010-12-21 | 2011-12-09 | Method for increasing embryo implantation rate in mother's uterus in mammals, use of an effective amount of beta - galactoside - binding lectin or derivatives thereof, beta - galactoside - binding lectin or derivatives and product. |
| EP11805370.1A EP2654897B1 (en) | 2010-12-21 | 2011-12-09 | Method for increasing embryo implantation rate in mother's uterus in mammals, use of an effective amount of beta-galactoside-binding lectin or derivatives thereof, beta-galactoside-binding lectin or derivatives and product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2654897T3 true PL2654897T3 (pl) | 2020-05-18 |
Family
ID=45463120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11805370T PL2654897T3 (pl) | 2010-12-21 | 2011-12-09 | Sposób zwiększania tempa implantacji zarodka w macicy matki u ssaków, zastosowanie skutecznej ilości lektyny wiążącej betagalaktozyd lub jej pochodnych, lektyna wiążąca betagalaktozyd lub pochodne i produkt |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9637533B2 (pl) |
| EP (2) | EP3623008A1 (pl) |
| JP (3) | JP6120374B2 (pl) |
| CN (2) | CN103702720B (pl) |
| BR (1) | BRPI1005702B1 (pl) |
| ES (1) | ES2756773T3 (pl) |
| PL (1) | PL2654897T3 (pl) |
| PT (1) | PT2654897T (pl) |
| RU (1) | RU2631598C2 (pl) |
| WO (1) | WO2012083396A1 (pl) |
| ZA (1) | ZA201304626B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1005702B1 (pt) | 2010-12-21 | 2020-02-04 | Inprenha Biotecnologia E Desenvolvimento Avancado Ltda Me | método para aumentar a taxa de implantação de embriões no útero materno em mamíferos, uso de uma quantidade eficaz de uma lectina ligante de beta-galactosídeo ou derivados da mesma e produto |
| EP3568700B1 (en) * | 2017-01-15 | 2022-09-28 | Arex Life Sciences, LLC | Methods for improving fertility in artificial insemination |
| EP4051432B8 (en) | 2019-10-29 | 2025-07-30 | TMRW Life Sciences, Inc. | Apparatus to facilitate transfer of biological specimens stored at cryogenic conditions |
| US11817187B2 (en) * | 2020-05-18 | 2023-11-14 | TMRW Life Sciences, Inc. | Handling and tracking of biological specimens for cryogenic storage |
| CN111658223A (zh) * | 2020-06-11 | 2020-09-15 | 上海滔华生物医药科技合伙企业（有限合伙） | 一种受体牛的筛选方法 |
| AU2021348066B2 (en) | 2020-09-24 | 2024-12-05 | TMRW Life Sciences, Inc. | Workstation and apparatus to facilitate transfer of biological specimens stored at cryogenic conditions |
| AU2021351505B2 (en) | 2020-10-02 | 2024-11-21 | TMRW Life Sciences, Inc. | Interrogation device and/or system having alignment feature(s) for wireless transponder tagged specimen containers and/or carriers |
| WO2022125817A1 (en) | 2020-12-10 | 2022-06-16 | TMRW Life Sciences, Inc. | Specimen holder with wireless transponder for attachment to secimen collection body |
| EP4252009B1 (en) | 2021-01-13 | 2025-03-05 | TMRW Life Sciences, Inc. | System to pick and/or place specimen containers |
| EP4412453A4 (en) | 2021-10-08 | 2025-01-22 | TMRW Life Sciences, Inc. | SYSTEMS, DEVICES AND METHODS FOR TAKING AND/OR PLACING SAMPLE CONTAINERS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869081A (en) * | 1996-06-28 | 1999-02-09 | The Population Council | Progesterone vaginal ring for treatment of infertility |
| TR200101538T2 (tr) * | 1998-11-30 | 2001-12-21 | Ivf Sciences Colorado, Inc. | In vitro dölleme sistemi ve sıralı kültür ortamı. |
| WO2001065928A1 (en) * | 2000-03-09 | 2001-09-13 | Yves Chicheportiche | A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells |
| RU2272630C2 (ru) * | 2004-04-28 | 2006-03-27 | ФГОУ ВПО "Курская государственная сельскохозяйственная академия им. проф. И.И. Иванова" | Способ повышения выживаемости эмбрионов у коров |
| US20070185014A1 (en) * | 2006-02-09 | 2007-08-09 | The Schepens Eye Research Institute, Inc. | Methods and compositions for modulating conjunctival goblet cells |
| EP1908476A1 (en) * | 2006-09-28 | 2008-04-09 | Charite-Universitätsmedizin Berlin | Galectin-2 for the treatment of inflammatory diseases of the skin |
| US20120175074A1 (en) * | 2010-10-21 | 2012-07-12 | Eastman Chemical Company | Nonwoven article with ribbon fibers |
| BRPI1005702B1 (pt) | 2010-12-21 | 2020-02-04 | Inprenha Biotecnologia E Desenvolvimento Avancado Ltda Me | método para aumentar a taxa de implantação de embriões no útero materno em mamíferos, uso de uma quantidade eficaz de uma lectina ligante de beta-galactosídeo ou derivados da mesma e produto |
-
2010
- 2010-12-21 BR BRPI1005702A patent/BRPI1005702B1/pt active IP Right Grant
-
2011
- 2011-12-09 ES ES11805370T patent/ES2756773T3/es active Active
- 2011-12-09 WO PCT/BR2011/000454 patent/WO2012083396A1/en not_active Ceased
- 2011-12-09 JP JP2013544976A patent/JP6120374B2/ja active Active
- 2011-12-09 EP EP19189687.7A patent/EP3623008A1/en not_active Withdrawn
- 2011-12-09 US US13/996,920 patent/US9637533B2/en active Active
- 2011-12-09 PL PL11805370T patent/PL2654897T3/pl unknown
- 2011-12-09 EP EP11805370.1A patent/EP2654897B1/en active Active
- 2011-12-09 CN CN201180068131.8A patent/CN103702720B/zh active Active
- 2011-12-09 RU RU2013133832A patent/RU2631598C2/ru active
- 2011-12-09 CN CN201811493360.4A patent/CN109966474A/zh active Pending
- 2011-12-09 PT PT118053701T patent/PT2654897T/pt unknown
-
2013
- 2013-06-21 ZA ZA2013/04626A patent/ZA201304626B/en unknown
-
2017
- 2017-01-05 JP JP2017000467A patent/JP2017081976A/ja not_active Withdrawn
-
2018
- 2018-10-01 JP JP2018186468A patent/JP6673998B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014500279A (ja) | 2014-01-09 |
| JP2019023208A (ja) | 2019-02-14 |
| EP3623008A1 (en) | 2020-03-18 |
| JP2017081976A (ja) | 2017-05-18 |
| PT2654897T (pt) | 2019-12-02 |
| CN103702720A (zh) | 2014-04-02 |
| US20140057858A1 (en) | 2014-02-27 |
| CN109966474A (zh) | 2019-07-05 |
| EP2654897B1 (en) | 2019-08-21 |
| CN103702720B (zh) | 2020-07-07 |
| JP6673998B2 (ja) | 2020-04-01 |
| RU2013133832A (ru) | 2015-01-27 |
| BRPI1005702B1 (pt) | 2020-02-04 |
| ES2756773T3 (es) | 2020-04-27 |
| BRPI1005702A2 (pt) | 2013-04-02 |
| US9637533B2 (en) | 2017-05-02 |
| EP2654897A1 (en) | 2013-10-30 |
| ZA201304626B (en) | 2014-09-25 |
| WO2012083396A1 (en) | 2012-06-28 |
| JP6120374B2 (ja) | 2017-04-26 |
| RU2631598C2 (ru) | 2017-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2654897T (pt) | Método para aumentar a taxa de implantação de embriões no útero da progenitora em mamíferos, utilização de uma quantidade eficaz de lectina de ligação a beta-galactósido ou seus derivados, lectina de ligação a beta-galactósido ou derivados e produto | |
| IL215842A0 (en) | Intrauterine system for use in medical treatment | |
| IL221160A (en) | 4,2,1-triazine-3-amine derivatives, a process for their preparation and use for drug preparation | |
| PH12013500892A1 (en) | Composition for use in the prevention and/or treatment of skin conditions and skin diseases | |
| IL244293A0 (en) | Pharmaceutical preparation and method of treatment for emergency contraception | |
| PH12013500876A1 (en) | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases | |
| IL236123A0 (en) | Preparations containing n-[4,2-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-4,1-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cftr-mediated disorders | |
| ZA201403596B (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease | |
| IL216967A0 (en) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | |
| EP2565289A4 (en) | An amorphous alloy die casting and the thermal treatment process thereof | |
| IL225793A0 (en) | Methods and preparations for curing insulin-related medical conditions | |
| HUE044715T2 (hu) | siRNS és felhasználása eljárásokban és kompozíciókban szembajok kezelésére és/vagy megelõzésére | |
| EP2709632A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES | |
| IL261269A (en) | Pharmaceutical preparations containing 7-(h1-imidazol-4-ylmethyl)-8,7,6,5-tetrahydro-quinoline for the treatment of skin diseases and conditions | |
| IL235410A0 (en) | A dental implant system with an oval plate and its components | |
| WO2010085799A9 (en) | Compositions and method for the treatment of parkinson's disease | |
| IL222482A0 (en) | Methods and compositions for the treatment of fluid accumulation in and/or under the retina | |
| EP2835191A4 (en) | CONTINUOUS CASTING MOLD FROM A TITANIUM OR TITANIUM ALLOY BLOCK AND CONTINUOUS CASTING DEVICE THEREWITH | |
| IT1400089B1 (it) | Composizione in polvere per la prevenzione e il trattamento delle patologie podali degli animali | |
| IT1396725B1 (it) | Metodo per prolungare e migliorare la funzionalita' di spermatozoi in vitro. | |
| SG10201501606VA (en) | Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders | |
| IL235095A0 (en) | Intrauterine application of 18-methyl-15 in cell, 16 in cell-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15 in cell, 16 in cell-methylene- 19-nor-20-spirox-4-en-3-one and their use in contraception and gynecological treatment | |
| IL222642A0 (en) | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males | |
| IL243237A0 (en) | Methods and preparations for the treatment of fluid accumulation in and/or under the retina | |
| EP2789332A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING DIAMINODIPHENYLSULFONE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH BONE MASS REDUCTION |